Scinovex
article Open Access

Controlled Sedation with Alphaxalone-Alphadolone

BMJ · 1974 · Vol. 2(5920) · pp. 656–659
Michael A. E. RamsayT.M. SavegeB. R. SimpsonRobert S. Goodwin

Abstract

Alphaxalone-alphadolone (Althesin), diluted and administered as a controlled infusion, was used as a sedative for 30 patients in an intensive therapy unit. This technique allowed rapid and accurate control of the level of sedation. It had three particularly useful applications: it provided "light sleep," allowed rapid variation in the level of sedation, and enabled repeated assessment of the central nervous system.Sedation was satisfactory for 86% of the total time, and no serious complications were attributed to the use of the drug. Furthermore, though alphaxalone-alphadolone was given for periods up to 20 days there was no evidence of tachyphylaxis or delay in recovery time.

Anesthesia and Sedative AgentsIntensive Care Unit Cognitive DisordersCardiac, Anesthesia and Surgical OutcomesSedationTachyphylaxisAnesthesiaSedativeMedicineIntensive care medicinePharmacology

MeSH terms

AdultAgedBlood PressureCentral Venous PressureChildDrug CombinationsElectroencephalographyFemaleHeart RateHumansHydroxysteroidsHypnotics and SedativesInfusions, ParenteralInjections, IntravenousIntensive Care Units
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

Controlled Sedation with Alphaxalone-Alphadolone · Scinovex